中航科工(02357.HK):中航規劃向中航建發科技收購北京銀燕100%股權
格隆匯 5 月 10日丨中航科工(02357.HK)發佈公吿,2021年5月10日,公司的全資附屬公司中航規劃與中航建發科技簽訂股權轉讓協議,據此,中航建發科技同意出售及中航規劃同意購買北京銀燕100%的股權,對價為人民幣6836.13萬元。緊隨轉讓完成後,中航規劃將持有北京銀燕100%的股權,中航建發科技將不再持有北京銀燕任何股權。
根據披露,北京銀燕為於中國境內成立的有限責任公司,主要從事加工、製造電子產品、塑料製品以及自有房產的物業管理。於本公吿日,北京銀燕為中航建發科技的全資附屬公司。緊隨轉讓完成後,中航規劃將持有北京銀燕100%的股權,中航建發科技將不再持有北京銀燕任何股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.